Viridian Therapeutics
VRDN
VRDN
51 hedge funds and large institutions have $60M invested in Viridian Therapeutics in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.15% more ownership
Funds ownership: 1.57% → 1.72% (+0.15%)
Holders
51
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.8M | |
| 2 | +$855K | |
| 3 | +$565K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$516K |
| 5 |
VF
Virtu Financial
New York
|
+$427K |
Top Sellers
| 1 | -$965K | |
| 2 | -$250K | |
| 3 | -$147K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$110K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$95K |